BDSX
NASDAQ
$19.81
Biodesix Inc (BDSX)
Biodesix, Inc. operates a data-driven diagnostic solutions company in the United States. The company is headquartered in Boulder, Colorado.
Sector:
Healthcare
Industry:
Diagnostics & Research
Buy
Target: $30.83 (+55.63%)
Market Cap
$212M
Free Cash Flow Yield
-11.83%
Beta (5Y)
0.45
Price Chart
Valuation
Market Cap$212M
P/S2.26
P/B23.96
Profitability
Total Revenue (TTM)$96M
Gross Profit (TTM)$78M
EBITDA-$19M
Profit Margin-30.5%
Operating Margin-24.3%
EPS-$3.91
Financial Health
Debt-to-Equity547.5%
Free Cash Flow Yield-11.83%
Growth & Risk
EPS 5Y CAGR-46.64%
Revenue 5Y CAGR+6.75%
FCF 5Y CAGR-11.95%
Beta (5Y)0.45
Sharpe Ratio1.52